FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

29,056 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 3000 - 3200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2451Influenza (Tests for influenza B virus Antigen)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2452Influenza (unspecified influenza virus in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2453Influenza (influenza B virus in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2454Influenza (Tests for unspecified influenza virus by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2455Influenza (Tests for influenza B virus by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2456Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2457Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2458Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2459Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2460Borrelia species (Tests by Microscopic Observation)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2461Borrelia species (Tests by Microscopic Observation in Blood)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2462Spirochetes (Tests by Microscopic Observation)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2463Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2464CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2465CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2466CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2467CRE (Tests for Enterobacterales species Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2468CRE (Combination Tests that include Enterobacterales by Culture and Identification)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2469Tests for Carbapenem Susceptibility [Meropenem and Doripenem]active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2470Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2471Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2473Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2474Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2475Aortic valve stenosis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2476Aortic valve stenosis (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2477Anotia (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2478Microtia (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2479Microtia (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2480Anotia (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2482Anophthalmia (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2483Anophthalmia (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2484Microphthalmia (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2485Microphthalmia (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2486Atrial septal defect (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2487Atrial septal defect (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2488Fetal Aortic valve stenosis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2489Congenital Posterior Urethral Valves (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2490Congenital Posterior Urethral Valves (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2491Bladder Exstrophy (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2492Bladder Exstrophy (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2493Encephalocele (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2494Fetal Encephalocele (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2495Encephalocele (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2496Choanal Atresia (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2497Choanal Atresia (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2498Cloacal Exstrophy (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2499Cloacal Exstrophy (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2500Renal Agenesis or Hypoplasia (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2501Renal Agenesis or Hypoplasia (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2502Trisomy 13 (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2503Trisomy 13 (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2504Fetal Trisomy 13 (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2505Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2506Galactosemia (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2507Galactosemia (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2508Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2509Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2510Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2511Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative])active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2512Galactosemia (Tests for Galactokinase (GALK) [Quantitative])active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2513Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative])active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2514Galactosemia (Tests for GALT gene allele 1)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2515Galactosemia (Tests for GALT gene allele 2)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2516Hypospadias (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2517Hypospadias (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2518Trisomy 18 (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2519Fetal Trisomy 18 (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2520Fetal Trisomy 18 (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2521Trisomy 18 (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2522Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2523Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2524Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2525Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2526Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2527Chlamydia species [Unspecified] (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2528Ventricular septal defect (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2529Ventricular septal defect (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2530Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2531Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2532Congenital Cytomegalovirus (Tests for CMV Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2533Congenital Cytomegalovirus (Tests for CMV Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.268Mumps (Tests for mumps virus IgM Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.272Present or Positive Lab Result Valueactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.282Varicella (Tests for Varicella zoster virus by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.283Varicella (Tests for Varicella zoster virus Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.285Encephalitis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.287Varicella (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.289Carbon Monoxide Poisoning (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.293Toxic Effects of Lead (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.297Measles (Tests for measles virus Nucleic Acid)active2025-03ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.299Measles (Tests for measles virus IgM Antibody)active2025-03ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.300Meningococcal Disease (Organism or Substance in Lab Results)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.301Shigellosis (Tests for Shigella species by Culture and Identification Method)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.307Leptospirosis (Tests for Leptospira IgM Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.308Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.310Bacteria (Tests by Culture and Identification Method)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.311Viruses (Tests by Culture and Identification Method)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.316Rubella (Tests for rubella virus IgM Antibody)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.317Shigellosis (Tests for Shigella species Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.319Fungi (Tests by Culture and Identification Method)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.322Pesticide Related Illness (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.329Apnea (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.330Apnea (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.333Shigellosis (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.335Influenza (Tests for influenza A virus by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.336Influenza (Tests for influenza A or B virus Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.340Influenza (influenza A or B virus in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.341Campylobacteriosis (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.342Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.343Campylobacteriosis (Tests for Campylobacter species Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.344Campylobacteriosis (Tests for Campylobacter species Antigen)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.349Hepatitis A (Tests for hepatitis A virus IgM Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.353Diarrhea (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.356HIV Infection (Organism or Substance in Lab Results)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.359Botulism (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.362Hansen’s Disease (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.365Silicosis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.366Silicosis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.371Cryptosporidiosis (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.372Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.375Cyclosporiasis (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.376Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.379Giardiasis (Tests for Giardia species Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.384Listeriosis (Tests for Listeria monocytogenes Nucleic Acid)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.386Vibriosis (Organism or Substance in Lab Results)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.388Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.390Trichinellosis (Tests for Trichinella species Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.395Syphilis (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.396Syphilis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.398Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.399Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.40STEC Infection (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.400Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.401Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.403Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.405Hantavirus Infection and Diseases (Disorders) (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.407Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.408Hepatitis B Virus Infection (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.422Tuberculosis (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.427STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.43Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.436Coccidioidomycosis (Tests for Coccidioides species IgM Antibody)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.437Coccidioidomycosis (Tests for Coccidioides species Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.438Coccidioidomycosis (Tests for Coccidioides species Antigen)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.44Gonorrhea [Cervicitis Urethritis] (Disorders) (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.445Legionellosis (Tests for Legionella species Antigen)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.446Legionellosis (Tests for Legionella species Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.451Tuberculosis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.460HIV Infection or AIDS (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.464Malaria (Tests for Plasmodium species Nucleic Acid)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.468Leptospirosis (Tests for Leptospira Nucleic Acid)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.471Leptospirosis (Tests for Leptospira Antibody [Quantitative] by Agglutination)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.472Leptospirosis (Tests for Leptospira Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.476Babesia species (Tests by Microscopic Observation in Blood)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.478Anthrax (Tests for Bacillus anthracis by Culture and Identification Method)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.479Anthrax (Tests for Bacillus anthracis Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.48Salmonellosis (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.480Anthrax (Tests for Bacillus anthracis Antigen)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.481Anthrax (Tests for Bacillus anthracis Antibody)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.494Ehrlichiosis (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.496Q Fever (Tests for Coxiella burnetii IgM IgG Antibody [Excluding Quantitative IFA Tests for IgG Antibody against Phase I or II Antigen])active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.500Q Fever (Tests for Coxiella burnetii Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.505Toxic Shock Syndrome (TSS) (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.507Toxic Shock Syndrome (TSS) (Disorders) (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.512Brucellosis (Tests for Brucella species Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.515Brucellosis (Tests for Brucella species Antibody [Quantitative])active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.516Brucellosis (Organism or Substance in Lab Results)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.519Dengue Virus Infection (Tests for dengue virus Nucleic Acid)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.523Dengue Virus Infection (Tests for dengue virus Antigen)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.524Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative])active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.525Dengue Virus Infection (Tests for dengue virus IgM Antibody)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.527Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative])active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.530Borrelia species (Tests for Nucleic Acid)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.531Lyme Disease (Tests for Borrelia burgdorferi IgM IgG Antibody by Immunoblot)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.532Lyme Disease (Tests for Borrelia burgdorferi Antibody by Immunoassay)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.534Smallpox (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.548St. Louis Encephalitis Virus Infection (Tests for Saint Louis encephalitis virus Antibody [Qualitative])active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.550Syphilis (Tests for Treponema pallidum Nucleic Acid)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.553Anaplasma species (Tests by Microscopic Observation)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.555Yellow Fever (Tests for yellow fever virus Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.557Yellow Fever (Tests for yellow fever virus Antibody [Quantitative])active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.56Diarrhea (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.560West Nile Virus Infection (Tests for West Nile virus Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.569Plague (Tests for Yersinia pestis Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.58Pertussis (Tests for Bordetella pertussis Nucleic Acid)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.595Tularemia (Tests for Francisella tularensis Nucleic Acid)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.598Tularemia (Tests for Francisella tularensis Antibody)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.6Diphtheria (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.605Organisms (Tests by Microscopic Observation by Acid Fast Stain)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.606Tuberculosis (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.614Pertussis (Tests for Bordetella pertussis Toxin Antibody)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.621Inspiratory Whoop (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.632Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.645Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.648Vomiting (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.650Jaundice (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.652Bacteria (Tests in Specimen from Normally Sterile Site by Culture and Identification Method)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.660Hypertonia [Excluding Congenital Hypertonia] (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.662Chest Pain (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.663Erythema Nodosum (SNOMED)active2024-01ushl7sct